Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.

T. Ohnoshi, S. Hiraki, N. Ueda, M. Fujii, K. Machida, H. Ueoka, S. Kawahara, A. Kozuka, K. Kiura, T. Moritaka

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds